Mutations that lead to FH inactivation can give rise to two distinct disorders: fumarate hydratase deficiency, an autosomal recessive disorder of metabolism, and hereditary leiomyomatosis and renal cell carcinoma (HLRCC), an autosomal dominant cancer syndrome with incomplete penetrance. Here, FH is linked to renal cell carcinoma.